How to access
This ESMO Webinar Series is available to all ESMO Members.
You will need to log in with your ESMO membership and click on the registration button. Access to the webinar will be open 30 min before the session starts.
Become an ESMO Member
Apply for an ESMO membership to register for this ESMO Webinar and enjoy all the benefits exclusive for members.
Live viewers of the webinar will be awarded a certificate of attendance and 1 ESMO-MORA category 1 point
Programme
5 min
Welcome and introduction
Pilar Garrido
20 min
Osimertinib after Chemoradiotherapy in Stage III EGFR-Mutated NSCLC
Mariana Brandao
20 min
RUBY Trial in Endometrial Cancer. Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin–paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial
Domenica Lorusso
15 min
Live Q&A and Discussion
All speakers
Learning objectives
- To discuss and critically evaluate notable recent publications.
- To enhance the understanding and application of the latest research in the field.
- To assess the study’s robustness, its significance to oncology practice, limitations, and its place within existing research.
- To identify and highlight any unclear aspects or unmet needs.